Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells
Abstract Background The ST6Gal-I glycosyltransferase, which adds α2-6-linked sialic acids to N-glycosylated proteins is upregulated in a wide range of malignancies including ovarian cancer. Prior studies have shown that ST6Gal-I-mediated sialylation of select surface receptors remodels intracellular...
Saved in:
Main Authors: | Kaitlyn A. Dorsett (Author), Robert B. Jones (Author), Katherine E. Ankenbauer (Author), Anita B. Hjelmeland (Author), Susan L. Bellis (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ST6Gal-I expression in ovarian cancer cells promotes an invasive phenotype by altering integrin glycosylation and function
by: Christie Daniel R, et al.
Published: (2008) -
Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death
by: Colleen M. Britain, et al.
Published: (2018) -
SOX17 expression in ovarian clear cell carcinoma
by: Daichi Kodama, et al.
Published: (2024) -
Downregulation of ST6GAL1 Promotes Liver Inflammation and Predicts Adverse Prognosis in Hepatocellular Carcinoma
by: Liu R, et al.
Published: (2022) -
Downregulation of ST6GAL2 Correlates to Liver Inflammation and Predicts Adverse Prognosis in Hepatocellular Carcinoma
by: Liu R, et al.
Published: (2024)